C
RXST icon

Covestor’s RxSight RXST Stock Holding History

Covestor’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
35
+25
+250% +$151 ﹤0.01% 2794
2026
Q1 		$0 Buy
10
+7
+233% +$58 ﹤0.01% 2705
2025
Q4 		$0 Hold
3
– – ﹤0.01% 2675
2025
Q3 		$0 Hold
3
– – ﹤0.01% 2700
2025
Q2 		$0 Sell
3
-68
-96% -$1.02K ﹤0.01% 2676
2025
Q1 		$2K Buy
71
+17
+31% +$505 ﹤0.01% 1880
2024
Q4 		$2K Buy
54
+33
+157% +$1.49K ﹤0.01% 1936
2024
Q3 		$1K Buy
21
+5
+31% +$256 ﹤0.01% 2088
2024
Q2 		$1K Buy
16
+4
+33% +$229 ﹤0.01% 2110
2024
Q1 		$1K Buy
12
+9
+300% +$442 ﹤0.01% 2093
2023
Q4 		$0 Sell
3
-1
-25% -$29 ﹤0.01% 2634
2023
Q3 		$0 Buy
+4
New +$119 ﹤0.01% 2624

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Covestor's RXST Position: Q2 2026 in Review

Covestor increased its RxSight (RXST) stake by 250% in Q2 2026, buying an estimated $151 and bringing the position to 35 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

Covestor first reported a position in RXST in Q3 2023 and has held it in 12 quarters since. The position peaked at $2K in Q1 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Covestor held 35 shares of RxSight worth $0 as of Q2 2026.
  • Covestor bought 25 RxSight shares in Q2 2026, an estimated $151.
  • RxSight made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2794 holding.
  • Covestor first reported a position in RxSight in Q3 2023 and has held it in 12 quarters since.
  • Covestor's RxSight position peaked at $2K in Q1 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.